Long-Term Analysis of Patients With Ewing Sarcoma Included in the Euro-EWING99 Study

The Journal of Clinical Oncology has published a long-term follow-up analysis of patients with Ewing sarcoma enrolled in the Euro-EWING99 multinational cooperative trial, one of the largest prospective studies in this rare bone malignancy. Euro-EWING99 randomized treatment strategies including chemotherapy intensification and high-dose therapy with stem-cell rescue. Detailed survival outcomes and late-effects data are expected in the full publication, which is currently ahead of print — no figures are available at this stage.